RXST - RxSight, Inc.
About RxSight, Inc. (https://www.rxsight.com)
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Eric J. Weinberg | Chief Business Development Officer | 1961 | $2,746,290 USD |
| Mark Wilterding | Chief Financial Officer | 1978 | $877,380 USD |
| Ronald Kurtz | President, Chief Executive Officer & Director | 1963 | $834,131 USD |
| Ilya Goldshleger | Chief Operating Officer | 1975 | $634,007 USD |
| Scott Gaines | Chief Customer Officer | 1969 | $472,053 USD |
| Adam Dashe | Executive Vice President of International | – | – |
| Jim Schindler | Executive VP & General Counsel | – | – |
| Maureen O'Connell | Executive Vice President of Clinical & Regulatory Affairs | – | – |
| Oliver Moravcevic | Vice President of Investor Relations | – | – |
| Patrick Cullen | Executive Vice President of Quality & Infrastructure Operations | – | – |
| Trent Campbell | Executive VP of US Sales & Commercial Strategy | – | – |